Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing

Description

Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing

Conditions

Cancer

Study Overview

Study Details

Study overview

Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing

Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing

Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing

Condition
Cancer
Intervention / Treatment

-

Contacts and Locations

Columbus

Ohio State University Wexner Medical Center, Columbus, Ohio, United States, 43210

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. A histologically or cytologically confirmed diagnosis of cancer
  • 2. Patients with any malignancy.
  • 3. Patients must have tumor suitable for research tumor biopsy (as assessed by trained specialists in interventional radiology) and Patients are medically fit to undergo a tissue biopsy or surgical procedure to get tumor tissue OR If Patients do not have a tumor suitable for biopsy but have another tissue available for molecular evaluation.
  • 4. Procedure-specific signed informed consent prior to initiation of any study-related procedures.
  • 5. Women and minorities are included in this protocol.
  • 6. Patients with multiple malignancies remain eligible.
  • 7. Patients with an inherited cancer syndrome or a medical history suggestive of an inherited cancer syndrome remain eligible.
  • 1. It is the enrolling study physicians discretion to decide if a patient is not fit enough to undergo tissue biopsy.
  • 2. Patients who are incarcerated are not eligible to participate.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Ohio State University Comprehensive Cancer Center,

Sameek Roychowdhury, MD, PhD, PRINCIPAL_INVESTIGATOR, Ohio State University Wexner Medical Center

Study Record Dates

2024-12-31